Mellinghoff Ingo (31 results)
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
US$ 187.86
US$ 15.85 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
US$ 187.86
US$ 15.85 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: New
US$ 187.83
US$ 19.85 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: Used - As new
US$ 199.56
US$ 2.64 shippingShips within U.S.A.Quantity: 1 available
Condition: As New. Unread book in perfect condition.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: New
US$ 187.83
US$ 19.85 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Condition: New.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: New
US$ 201.06
US$ 2.64 shippingShips within U.S.A.Quantity: 1 available
Condition: New.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: New
US$ 201.08
US$ 2.64 shippingShips within U.S.A.Quantity: Over 20 available
Condition: New.
Language: English
Published by Springer Berlin Heidelberg 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: moluna, Greven, , Germanymoluna
Contact seller5-star sellerCondition: New
US$ 160.93
US$ 56.22 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New.
Language: English
Published by Springer Berlin Heidelberg 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: moluna, Greven, , Germanymoluna
Contact seller5-star sellerCondition: New
US$ 160.93
US$ 56.22 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Gebunden. Condition: New.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: Used - As new
US$ 207.64
US$ 19.85 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Condition: As New. Unread book in perfect condition.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: New
US$ 225.00
US$ 3.99 shippingShips within U.S.A.Quantity: 4 available
Condition: New. pp. 246.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: New
US$ 236.63
US$ 3.99 shippingShips within U.S.A.Quantity: 4 available
Condition: New. pp. 246 Index.
More imagesLanguage: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
US$ 165.47
US$ 80.33 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Therapeutic Kinase Inhibitors | Ingo K. Mellinghoff (u. a.) | Taschenbuch | Current Topics in Microbiology and Immunology | x | Englisch | 2014 | Springer | EAN 9783642445804 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]spring…er[dot]com | Anbieter: preigu.
Language: English
Published by Springer Berlin Heidelberg, Springer Berlin Heidelberg 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
US$ 189.68
US$ 71.93 shippingShips from Germany to U.S.A.Quantity: 1 available
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, a…re increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
US$ 197.54
US$ 71.01 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regi…mens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: Buchpark, Trebbin, , GermanyBuchpark
Contact seller5-star sellerCondition: Used - Fine
US$ 146.80
US$ 120.49 shippingShips from Germany to U.S.A.Quantity: 1 available
Condition: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as ¿chemotherapy¿ and still the backbone of most cancer treatment regi…mens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
Seller: Revaluation Books, Exeter, , United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
US$ 269.09
US$ 13.23 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Paperback. Condition: Brand New. reprint edition. 234 pages. 8.75x6.00x0.50 inches. In Stock.
Language: English
Published by Springer Verlag 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: Revaluation Books, Exeter, , United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
US$ 270.75
US$ 13.23 shippingShips from United Kingdom to U.S.A.Quantity: 2 available
Hardcover. Condition: Brand New. 2012 edition. 244 pages. 9.25x6.25x0.75 inches. In Stock.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: Used - As new
US$ 306.62
US$ 19.85 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: As New. Unread book in perfect condition.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: Mispah books, Redhill, SURRE, United KingdomMispah books
Contact seller4-star sellerCondition: Used - As new
US$ 295.73
US$ 33.08 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: Used - As new
US$ 326.20
US$ 2.64 shippingShips within U.S.A.Quantity: Over 20 available
Condition: As New. Unread book in perfect condition.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
- Print on Demand
Seller: Brook Bookstore On Demand, Napoli, NA, ItalyBrook Bookstore On Demand
Contact seller3-star sellerCondition: New
US$ 149.23
US$ 6.31 shippingShips from Italy to U.S.A.Quantity: Over 20 available
Condition: new. Questo è un articolo print on demand.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
- Print on Demand
Seller: Brook Bookstore On Demand, Napoli, NA, ItalyBrook Bookstore On Demand
Contact seller3-star sellerCondition: New
US$ 149.23
US$ 6.31 shippingShips from Italy to U.S.A.Quantity: Over 20 available
Condition: new. Questo è un articolo print on demand.
Language: English
Published by Springer Berlin Heidelberg Apr 2014 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
US$ 189.68
US$ 26.39 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cance…r treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert. 244 pp. Englisch.
Language: English
Published by Springer Berlin Heidelberg Mrz 2012 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
US$ 189.68
US$ 26.39 shippingShips from Germany to U.S.A.Quantity: 2 available
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treat…ment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editors invited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authors hope these lessons will be instructive for the novice as well as the expert. 244 pp. Englisch.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
- Print on Demand
Seller: Majestic Books, Hounslow, , United KingdomMajestic Books
Contact seller4-star sellerCondition: New
US$ 236.56
US$ 8.60 shippingShips from United Kingdom to U.S.A.Quantity: 4 available
Condition: New. Print on Demand pp. 246 30 Illus. (21 Col.).
Language: English
Published by Springer Berlin Heidelberg, Springer Berlin Heidelberg Mär 2012 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
US$ 189.68
US$ 68.85 shippingShips from Germany to U.S.A.Quantity: 1 available
Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as ¿chemotherapy¿ and still the backbone of most cancer treatment… regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates.This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 244 pp. Englisch.
Language: English
Published by Springer Berlin Heidelberg, Springer Berlin Heidelberg Apr 2014 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
US$ 189.68
US$ 68.85 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as ¿chemotherapy¿ and still the backbone of most cancer tr…eatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 244 pp. Englisch.
Language: English
Published by Springer 2014
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Softcover
- Print on Demand
Seller: Biblios, frankfurt am main, HESSE, GermanyBiblios
Contact seller4-star sellerCondition: New
US$ 251.90
US$ 11.42 shippingShips from Germany to U.S.A.Quantity: 4 available
Condition: New. PRINT ON DEMAND pp. 246.
Language: English
Published by Springer 2012
Series: Current Topics in Microbiology and Immunology, Book 151 of 322. Book 151 of 322 - Current Topics in Microbiology and Immunology
- Hardcover
- Print on Demand
Seller: Majestic Books, Hounslow, , United KingdomMajestic Books
Contact seller4-star sellerCondition: New
US$ 248.46
US$ 8.60 shippingShips from United Kingdom to U.S.A.Quantity: 4 available
Condition: New. Print on Demand pp. 246 30 Illus. (21 Col.).
